COMPASS Pathways plc (CMPS) Quarterly EPS earnings growth

COMPASS Pathways plc - graphic logo of issuer CMPS

Quarterly earnings per share growth illustrates the asset-light approach of COMPASS Pathways plc (CMPS), which delegates drug synthesis to external plants. Its status as the leading innovator in psychedelic therapy strengthens physician confidence, while patents for depression treatment protocols secure future revenue. Meanwhile, the value of 78.30 describes the current level of the issuer's financial stability, which is presently in a stage of neutral sideways movement.

COMPASS Pathways (CMPS) - Year-over-year earnings per one share growth for the last 12 months from 07/04/2022 to 11/10/2026

Analytical breakdowns and data insights for company COMPASS Corp (CMPS)

- share price and consensus valuation forecast:
Stock Quotes COMPASS Pathways|CMPS - Average Forecast Price
- market capitalization details:
Market Capitalization Compass Pathways|CMPS - Real Price to Acquire Entire Company
- balance sheet net asset value indicators:
Book Value per Share COMPASS Pathways|CMPS - Accounting Value of Company|Market Value to Book Value Ratio compasspathways.com|CMPS - Company Assets
- debt and liquidity details:
Total Debt to Capital COMPASS Pathways plc|CMPS - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity COMPASS Pathways plc|CMPS - Company Cumulative Debt|Debt to Book Capitalization Ratio Compass Pathways|CMPS - Company Long-Term Liabilities|Company Short-Term Debt COMPASS Pathways|Quick Ratio compasspathways.com
- earnings and valuation multiples indicators:
CMPS - Net Profit|Expected Profit COMPASS Pathways plc|CMPS - Business Payback Period|Future Price to Earnings Compass Pathways|CMPS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Compass Pathways|CMPS - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months COMPASS Pathways|CMPS - Earnings per one share for the last 12 months|Quarterly EPS earnings growth compasspathways.com|CMPS - Earnings growth in current year|Expected earnings per share growth for next year COMPASS Pathways plc
Comprehensive company analysis:COMPASS Pathways plc
Flagship merchandise of COMPASS Pathways plc

As a portfolio manager, I view this indicator as a tool for assessing net earnings per share dynamics. The metric captures the percentage change in profit between quarters, converting discrete data into a continuous flow. By analyzing the quarterly EPS trajectory, an investor determines the business scaling rate. For COMPASS Pathways plc (CMPS) with its asset-light model and outsourced psilocybin synthesis, this indicator reflects the efficiency of R&D expenditures. This allows for the separation of operating expenses from the actual growth of shareholder value.

Main competitors

ALKS (Alkermes) - Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Avadel Pharmaceuticals PLC (AVDL)|ATAI (atai Life Sciences Corp) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months GH Research Group (GHRS)|Quarterly EPS earnings growth MNMD|LBRX (lbpharma.us) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Bright Minds Biosciences Inc. DRUG|Vanda Pharma (VNDA) - Earnings per share growth in annualized terms for the last twelve months|Cybin Corp - Quarterly EPS earnings growth|Alto Neuroscience Corp (ANRO) - Year-over-year net earnings per share growth for the last 12 months|NRx Pharmaceuticals (NRXP) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Cingulate (CING)|Year-over-year earnings per share growth for the last twelve months Silo Pharma|Year-over-year net earnings per share growth for the last 12 months China Pharma (CPHI)|Year-over-year earnings per share growth for the last twelve months Clearmind Medicine Inc. (CMND)|PBM: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth SPRC (SciSparc Ltd)|Quarterly EPS earnings growth seelostherapeutics.com SEEL|VRPX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Karuna Therapeutics Inc KRTX